MedPath

Clinical study of nuclear alterations in patients undergoing in-office tooth whitening

Phase 4
Conditions
Genotoxicity
SP3.311.300.312.289.400
Registration Number
RBR-4ttb63q
Lead Sponsor
Faculdade de Odontologia - Universidade Federal do Amazonas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Both sexes; age between 14 and 18 years old and 31 and 50 years old; no systemic diseases (metabolic, immunological and heart diseases); with oral condition free from carious lesions or periodontal diseases; central incisor or canine color A2 or darker; six upper anterior teeth free of restorations on the buccal surface; healthy enamel; dissatisfaction with the color of your teeth; no pathological changes; physiological and medicinal

Exclusion Criteria

Dentin hypersensitivity; smoker; alcoholic; pregnant or breastfeeding; orthodontic appliance; severe crowding, presence of intrinsic spots and ages between 19 and 30 years old

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the genotoxicity of tooth whitening between age groups using the micronucleus test. For the whitening procedure to be considered safe, it is expected not to find an average difference greater than 1
Secondary Outcome Measures
NameTimeMethod
Evaluate the difference in the frequency of micronuclei between different age groups; evaluate the frequency of other nuclear alterations (karyolysis, karyorrhex, pycnosis, condensed chromatin, binucleated cells and nuclear button) in the gingiva of young and adult patients undergoing in-office tooth whitening
© Copyright 2025. All Rights Reserved by MedPath